Science
The Vaccine That Learned to Think: How AI Just Passed Its First Human Trial
An AI-designed universal vaccine called pEVAC-PS has passed its first human clinical trial, showing immune responses against multiple coronaviruses. Here's why this changes the game for pandemic prevention.
Lavamgam AIJun 15, 20266 min read read
The Signal
A vaccine called pEVAC-PS — designed from scratch by artificial intelligence — has cleared its first human clinical trial, and the implications reach far beyond a single successful lab result. For the first time, researchers at the Universities of Cambridge and Southampton tested a vaccine on humans whose active component was dreamed up not by a biologist staring at a microscope, but by computer simulations running millions of protein calculations. The results, published in the...
AI vaccine design
universal vaccine
pEVAC-PS
coronavirus
pandemic preparedness
clinical trial
Cambridge University
Share